Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Donor-specific Cellular Alloresponse Assessment for Immunosuppression Minimization in de Novo Renal Transplantation

NCT02540395 is registered in ClinicalTrials.gov with Prof. Dr. Petra Reinke as lead sponsor.

NCT NCT02540395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02540395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Donor-specific Cellular Alloresponse Assessment for Immunosuppression Minimization in de Novo Renal Transplantation
Lead sponsor
Prof. Dr. Petra Reinke
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2015
Completion date
October 31, 2020
Enrollment
184 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

disorder related to renal transplantation, effects of immunosuppressant therapy